Patents by Inventor James C. Lanter

James C. Lanter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel Benzimidazole Derivatives Useful as Selective Androgen Receptor Modulators (SARMS)
    Publication number: 20090258909
    Abstract: The present invention is directed to novel benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Application
    Filed: June 22, 2009
    Publication date: October 15, 2009
    Inventors: Raymond Ng, Zhihua Sui, Jihua Guan, James C. Lanter, Vernon C. Alford, JR.
  • 3,4-diamino-3-cyclobutene-1,2-dione derivatives as potassium channel openers
    Patent number: 7595409
    Abstract: The present invention is directed to novel 3,4-diamino-3-cyclobutene-1,2-dione derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders related to potassium channel.
    Type: Grant
    Filed: March 29, 2007
    Date of Patent: September 29, 2009
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: James C. Lanter, Zhihua Sui
  • NOVEL INDOLE DERIVATIVES AS SELECTIVE ANDROGEN RECEPTOR MODULATORS (SARMS)
    Publication number: 20090216023
    Abstract: The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Application
    Filed: August 8, 2008
    Publication date: August 27, 2009
    Inventors: James C. Lanter, Zhihua Sui, James J. Fiordeliso, Weiqin Jiang, Xuqing Zhang
  • Novel imidazolidIn-2-one derivatives as selective androgen receptor modulators (SARMS)
    Publication number: 20090215848
    Abstract: The present invention is directed to novel imidazolidin-2-one derivatives having a structure according to Formula I wherein a, b, R1, R2, R3, and R4 are as defined above, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Application
    Filed: March 30, 2009
    Publication date: August 27, 2009
    Inventors: James C. Lanter, Zhihua Sui
  • Benzimidazole derivatives useful as selective androgen receptor modulators (sarms)
    Patent number: 7566733
    Abstract: The present invention is directed to novel benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Grant
    Filed: September 26, 2005
    Date of Patent: July 28, 2009
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Raymond Ng, Zhihua Sui, Jihua Guan, James C. Lanter, Vernon C. Alford, Jr.
  • Imidazolidin-2-one derivatives as selective androgen receptor modulators (SARMS)
    Patent number: 7531565
    Abstract: The present invention is directed to novel imidazolidin-2-one derivatives having a structure according to Formula I wherein a, b, R1, R2, R3, and R4 are as defined above, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Grant
    Filed: September 9, 2005
    Date of Patent: May 12, 2009
    Assignee: Janssen Pharmaceutica, N.V.
    Inventors: James C. Lanter, Zhihua Sui
  • Indole derivatives as selective androgen receptor modulators (SARMS)
    Patent number: 7427682
    Abstract: The present invention is directed to novel insole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Grant
    Filed: April 1, 2005
    Date of Patent: September 23, 2008
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: James C. Lanter, Zhihua Sui, James J. Fiordeliso, Weiqin Jiang, Xuqing Zhang
  • Benzimidazole derivatives useful as selective androgen receptor modulators (SARMS)
    Patent number: 7348438
    Abstract: The present invention is directed to novel benzimidazole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Grant
    Filed: September 26, 2005
    Date of Patent: March 25, 2008
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: Raymond Ng, Zhihua Sui, Jihua Guan, James C. Lanter, Vernon C. Alford, Jr.
  • Indole derivatives as selective androgen receptor modulator (SARMS)
    Patent number: 7288553
    Abstract: The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Grant
    Filed: April 1, 2005
    Date of Patent: October 30, 2007
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: James C. Lanter, Zhihua Sui, James J. Fiordeliso, Weiqin Jiang, Xuqing Zhang
  • Indole derivatives as selective androgen receptor modulators (SARMS)
    Patent number: 7282507
    Abstract: The present invention is directed to novel indole derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Grant
    Filed: April 1, 2005
    Date of Patent: October 16, 2007
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: James C. Lanter, Zhihua Sui, James J. Fiordeliso, Weiqin Jiang, Xuqing Zhang
  • 3,4-DIAMINO-3-CYCLOBUTENE-1,2-DIONE DERIVATIVES AS POTASSIUM CHANNEL OPENERS
    Publication number: 20070232689
    Abstract: The present invention is directed to novel 3,4-diamino-3-cyclobutene-1,2-dione derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders related to potassium channel.
    Type: Application
    Filed: March 29, 2007
    Publication date: October 4, 2007
    Inventors: James C. Lanter, Zhihua Sui
  • 2-(quinolonyl)-fused heterocycles as androgen receptor modulators
    Patent number: 6858621
    Abstract: The present invention is directed to novel 2-(quinolonyl)-fused heterocyclyl derivatives of the general formula (I) wherein R1, R2, R3, R3a, R4, R5, R6 and R7 are as herein defined, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions modulated by the androgen receptor.
    Type: Grant
    Filed: April 11, 2003
    Date of Patent: February 22, 2005
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: James C. Lanter, Zhihua Sui, James J. Fiordeliso
  • Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
    Patent number: 6818646
    Abstract: The invention relates to novel pyrrolopyridinone derivatives of the formula (I) or (II): pharmaceutical compositions containing the compounds and their use for the treatment of sexual dysfunction.
    Type: Grant
    Filed: August 11, 2003
    Date of Patent: November 16, 2004
    Inventors: Zhihua Sui, Mark J. Macielag, Jihua Guan, Weigin Jiang, James C. Lanter
  • 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
    Patent number: 6765011
    Abstract: The present invention is directed to novel 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives of the general formula (I) or (II) wherein all variables are as herein defined, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions associated with gonadotropin releasing hormone (GnRH). The compounds of the invention are antagonists of GnRH, useful in the treatment of the infertility, prostate cancer, benign prostate hyperplasia (BPH) and as contraceptives.
    Type: Grant
    Filed: April 3, 2003
    Date of Patent: July 20, 2004
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Zhihua Sui, Mark Macielag, James C. Lanter
  • Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
    Publication number: 20040044021
    Abstract: The invention relates to novel pyrrolopyridinone derivatives of the formula (I) or (II): 1
    Type: Application
    Filed: August 11, 2003
    Publication date: March 4, 2004
    Inventors: Zhihua Sui, Mark J. Macielag, Jihua Guan, Weigin Jiang, James C. Lanter
  • 2-(Quinolonyl)-fused heterocycles as androgen receptor modulators
    Publication number: 20040014743
    Abstract: The present invention is directed to novel 2-(quinolonyl)-fused heterocyclyl derivatives of the general formula (I) 1
    Type: Application
    Filed: April 11, 2003
    Publication date: January 22, 2004
    Inventors: James C. Lanter, Zhihua Sui, James J. Fiordeliso
  • 7-Heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives useful as antagonists of gonadotropin releasing hormone
    Publication number: 20030216429
    Abstract: The present invention is directed to novel 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives of the general formula (I) or (II) 1
    Type: Application
    Filed: April 3, 2003
    Publication date: November 20, 2003
    Inventors: Zhihua Sui, Mark Macielag, James C. Lanter
  • Substituted pyrrolopyridinone derivatives useful as phosphodiesterase inhibitors
    Patent number: 6635638
    Abstract: The invention relates to novel pyrrolopyridinone derivatives of the formula (I) or (II): pharmaceutical compositions containing the compounds and their use for the treatment of sexual dysfunction.
    Type: Grant
    Filed: May 2, 2001
    Date of Patent: October 21, 2003
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Zhihua Sui, Mark J. Macielag, Jihua Guan, Weiqin Jiang, James C. Lanter
  • 7-heterocyclyl quinoline and thieno[2,3-b]yridine derivatives useful as antagonists of gonadotropin releasing hormone
    Patent number: 6583153
    Abstract: The present invention is directed to novel 7-heterocyclyl quinoline and thieno[2,3-b]pyridine derivatives of the general formula (I) or (II) wherein all variables are as herein defined, pharmaceutical compositions containing them and their use in the treatment of disorders and conditions associated with gonadotropin releasing hormone (GnRH). The compounds of the invention are antagonists of GnRH, useful in the treatment of the infertility, prostate cancer, benign prostate hyperplasia (BPH) and as contraceptives.
    Type: Grant
    Filed: November 14, 2001
    Date of Patent: June 24, 2003
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: Zhihua Sui, Mark Macielag, James C. Lanter
  • Neurotrophic 2-azetidinecarboxylic acid derivatives, and related compositions and methods
    Patent number: 6544976
    Abstract: This invention provides compounds having the following general structure: This invention also provides pharmaceutical compositions comprising same and methods of using these compositions to treat and prevent disorders characterized by neuronal damage.
    Type: Grant
    Filed: June 12, 2000
    Date of Patent: April 8, 2003
    Assignee: Ortho-McNeil Pharmaceutical, Inc.
    Inventors: James C. Lanter, Suying Zhang, Boyu Zhao